Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision-making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, drug response prediction, and development of companion diagnostics.
We are a CRO specialising in the analysis of proteins and their associated PTM’s via advanced Mass Spectrometry. By using proprietary methodologies, we can detect up to 8,000 proteins per sample in Discovery mode and can offer multiplexed assays of up to 100 proteins/sample in a GCLP accredited Targeted assay.
With their proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.
With over 15 years of experience in genetic and epigenetic clinical research, EpigenDx offers high quality products and laboratory services focused on DNA methylation analysis, gene expression profiling, and mutation analysis. Our scientific teams carefully evaluate each project and establish analysis procedures using best fit technologies, including NGS, Pyrosequencing, RT-PCR, digital PCR, and GeneChip Microarray. Our popular services include Line-1 global methylation tests and Foxp3-TSDR analysis for epigenetic immunotherapy. Our GLP compliant and CLIA certified services make us the perfect partner during pre-clinical research and diagnostic test development.
Bionano transform the way the world sees the genome through Optical Genome Mapping solutions, diagnostic services, and software. Bionano Saphyr® system offers an extremely long-read technology, providing unmatched sensitivity to detect any type of structural variation (SV) and copy number variation (CNV), unbiased and genome wide, at low cost.
Different from sequencing and by leveraging direct visualization of whole-genome DNA molecules, Bionano workflow can resolve complex repetitive regions, and Bionano’s high coverage depth can identify low allele fraction event.
Delivering innovative tools to basic and translational researchers. Our focus is directed towards advancing cellular analysis with flow cytometry cell analysers and sorters, fluorescently conjugated monoclonal antibodies as well as systems for single cell multiomics analysis. Bespoke antibody formulations, applications and assay design/development/optimization support as well as specific product training deliver holistic solutions to meet diverse customer needs.
Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology that can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. For further information on Lunaphore and its products, please visit www.lunaphore.com
TransCure bioServices (TCS) provides predictive in vivo pharmacology expertise for drug pre-clinical candidate selection in the fields of infectious, cancer (IO, PDX), inflammation, vaccine and immune disease areas. We are the only preclinical CRO providing commercially HIV, immuno-oncology (IO) therapy, PDX, IBD, vaccine and autoimmune mouse models with a fully functional reconstituted HUMAN IMMUNE SYSTEM (hu-mouse models). We co-design study protocols/experiments performing the ordered studies and providing comprehensive data collection, data analysis and reports.
Veracyte is a pioneering, global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions. Our growing menu of advanced diagnostic tests help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment. Veracyte offers customized multi-omics tools and expertise to our biopharmaceutical partners, helping them advance their therapeutic discovery, development and commercialization programs.
At Biognosys, we believe that proteome insights unfold breakthrough discoveries that can dramatically improve human health. With our versatile portfolio of proprietary next-generation proteomics services, software, and kits, we provide a multi-dimensional view of protein expression, function, and structure in all sample types. Our patented technologies utilize high-resolution mass spectrometry, and through advanced data analytics, we translate data into actionable insights for R&D and clinical research.
Cureline, Inc. is a global contract research organization (CRO) and a commercial biobank supporting preclinical research in oncology, hematology, immune-oncology and various other therapeutic areas (Cardio-vascular, metabolic, neuro-degenerative, infectious and inherited conditions) to the pharmaceutical, biotechnology, and medical device industries worldwide since 2003.
Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets. With over 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions.
Agilent brings the power of precision medicine to customers, partners, and patients. Agilent is a partner of choice to pharmaceutical and biotech companies producing innovative diagnostics and therapeutics for the benefit of patients around the world.
Canopy Biosciences(r), a Bruker company, empowers innovation by providing access to cutting-edge spatial biology and multi-omic tools so biomedical researchers can drive scientific discovery faster. We offer instruments and services for spatial proteomics and transcriptomics, gene expression profiling, and CLIA services for IHC, FISH and histopathology. Learn more by visiting CanopyBiosciences.com.
Quantabio is a leading provider of advanced DNA and RNA amplification reagents for the most demanding molecular testing applications in applied, translational, and life science research. Our team leverages decades of experience in developing pioneering amplification technologies to deliver cutting-edge products to researchers focused on critical cloning, PCR, qPCR, and Next-Generation Sequencing (NGS) applications.
Based in Beverly, Massachusetts, Quantabio offers a growing portfolio of products through its international sales operations, as well as a global network of distributors and commercial service providers.
Genefirst are a molecular diagnostics company focused on cancer diagnostics and personalised medicine. We offer robust, easy-to-use and sensitive molecular diagnostics solutions to researchers, clinicians and drug companies to enable accurate diagnosis and delivery of safe and effective medicines. Key products include our HPV High Risk genotyping kit (Papilloplex), which does so in a single tube and our ATOM-Seq NGS technologies which includes cancer panels and a custom panel service to support drug development and clinical trials.
PeproTech is a business unit within the Thermo Fisher Scientific Biosciences Division, specializing in manufacturing high quality cytokine products and providing exceptional service to the global life science and cell therapy markets. Our products include Recombinant Human, Murine and Rat Cytokines, Animal-Free Recombinant Cytokines, GMP Cytokines, Antibodies and ELISA Kits.
Talem Therapeutics is a biotherapeutic company and a wholly owned subsidiary of ImmunoPrecise Antibodies (IPA) that leverages IPA’s antibody discovery and development expertise combined with AI/bioinformatics to generate valuable assets (best-in-class / first-in-class) for out-licensing and co-development. Talem's experts focus on next generation antibodies from target validation through IND-Readiness (indication agnostic).